Meet us at SOT 2022 and See How NeuCyte is Revolutionizing Neurotoxicity Assessment with Unprecedented predictive Power
HiPSC-derived neural cultures have shown great promise as an alternative to animal models and primary cultures for neurotoxicity testing. Here we present the development and validation of a highly efficient and predictive hiPSC-derived neuronal/glial in vitro co-culture approach for quantitative assessment of neurological liabilities of compounds in a medium-throughput setting.
Join our scientific presentation
The system is composed of an established assay setup and optimized data analysis pipeline. We have tested 40 compounds on this assay system so far, for all of which our neurotoxicity risk prediction demonstrated excellent correlation with known clinical or animal data. We believe this may represent the future of fast and high throughput neurotoxicity assessment for early drug discovery for pharmaceutical industry and environmental impact of agricultural compounds.
Exhibitor Hosted Session:
Establishing an In Vitro Assay for Effectively Predicting Neurotoxicity Risks Using Functional Human
Date: March 29, 2022
Time: 12:00 PM-01:00 PM
Hui Liu, PhD
Head of Drug Discovery
Lunch will be provided!